Utama › Kanser Payudara › New Jersey › Clifton
Kajian klinikal Kanser Payudara di Clifton, NJ
12 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Clifton (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Mengambil pesertaFasa 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Mengambil pesertaFasa 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack · 7 mi jauh
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Mengambil pesertaFasa 3
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack · 7 mi jauh
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Mengambil pesertaFasa 3
- John Theurer Ctr-Hackensack UMC, Hackensack · 7 mi jauh
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Mengambil pesertaFasa 2
- Hackensack Meridian Health, Hackensack · 7 mi jauh
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Mengambil pesertaFasa 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- Hackensack University Medical Center, Hackensack · 7 mi jauh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi jauh
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Mengambil pesertaFasa 3
- Hackensack University Medical Center, Hackensack · 7 mi jauh
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Mengambil pesertaFasa 1
- Hackensack University Medical Center, Hackensack · 7 mi jauh
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Mengambil pesertaKajian pemerhatian
- John Theurer Cancer Center, Hackensack · 7 mi jauh
Kajian Kanser Payudara di bandar lain
- New York City, NY136 kajian
- Houston, TX126 kajian
- Boston, MA112 kajian
- Nashville, TN81 kajian
- Los Angeles, CA73 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Queens, NY64 kajian
- Durham, NC64 kajian
- Chicago, IL59 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di Clifton
- Kanser Paru-paru Bukan Sel Kecil24 kajian
- Kanser (semua jenis)15 kajian
- Mieloma Pelbagai14 kajian
- Kanser Metastatik12 kajian
- Leukemia Mieloid Akut12 kajian
- Kanser Prostat12 kajian
- Kanser Ovari11 kajian
- Kanser Paru-paru10 kajian
- Kanser Kolorektal8 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher8 kajian
- Kanser Endometrium8 kajian
- Kegagalan Jantung8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.